Loyola Marymount University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Loyola Marymount University sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Loyola Marymount University: 7 sponsored US clinical trials, 2 recruiting.
Loyola Marymount University sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Substance Use, with 1 trials.
Upper-quartile sponsor footprint
Loyola Marymount University sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
NCT07042451
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
NCT06191939
Digitally Prompted Parenting: A Text Message Parent-Based Alcohol Intervention for Incoming College Students
NCT06861660
2 College Truths and 1 Lie
NCT06576011
Revolutionizing Normative Re-education
NCT04356261
Parent Feedback Intervention Targeting Student Transitions and Alcohol Related Trajectories (+) Efficacy Study
NCT04549454
A Gamified, Social Media Inspired Personalized Normative Feedback Alcohol Intervention for Sexual Minority Women
NCT03884478
Therapeutic Areas
What is open in the Loyola Marymount University pipeline
2 recruiting of 7 indexed (29% open); 5 completed (71%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Substance Use (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Loyola Marymount University: open-pipeline peers nationwide
Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Loyola Marymount University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- AlloSource · 29% recruiting · 7 trials
- Alnylam Pharmaceuticals · 29% recruiting · 49 trials
- Annovis Bio · 29% recruiting · 7 trials
Related
What to do with this Loyola Marymount University page
7 registered trials is a research-attention snapshot, not an endorsement of Loyola Marymount University or any single study.
- 2 of Loyola Marymount University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Substance Use is the condition Loyola Marymount University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Substance Use trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Loyola Marymount University pipeline card: 7 registered trials from official public datasets.Report a data error.